The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.
about
Genetic, epigenetic and environmental impact on sex differences in social behavior.Role of kappa-opioid receptors in stress and anxiety-related behavior.Targeting memory processes with drugs to prevent or cure PTSDInvolvement of noradrenergic transmission in the PVN on CREB activation, TORC1 levels, and pituitary-adrenal axis activity during morphine withdrawalRole of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc)Effects of corticotropin releasing factor (CRF) on sleep and temperature following predictable controllable and uncontrollable stress in miceImportance of stress receptor-mediated mechanisms in the amygdala on visceral pain perception in an intrinsically anxious ratDifferential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.Overlapping neurobiology of learned helplessness and conditioned defeat: implications for PTSD and mood disorders.Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal modelsRole of CRF receptor signaling in stress vulnerability, anxiety, and depression.Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxietyEffect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fearSelective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responsesCorticotropin releasing factor (CRF) modulates fear-induced alterations in sleep in mice.Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent ratsCorticotropin-releasing factor receptors in the dorsal raphe nucleus modulate social behavior in Syrian hamsters.Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes.Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primatesFacilitation of cardiac vagal activity by CRF-R1 antagonists during swim stress in ratsAlternative strategies for the treatment of classical congenital adrenal hyperplasia: pitfalls and promisesCorticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in miceThe effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in ratsOn the role of corticotropin-releasing hormone receptors in anxiety and depressionTreatment with CRH-1 antagonist antalarmin reduces behavioral and endocrine responses to social stressors in marmosets (Callithrix kuhlii).Controversies about a common etiology for eating and mood disorders.Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats.Treatment with a CRH-R1 antagonist prevents stress-induced suppression of the central neural drive to the reproductive axis in female macaquesIntegration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonistCorticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety.Chemical neuroimmunology: health in a nutshell bidirectional communication between immune and stress (limbic-hypothalamic-pituitary-adrenal) systems.Nicotine stimulates secretion of corticosterone via both CRH and AVP receptors.Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear.Corticotropin-releasing hormone receptors in the medial prefrontal cortex regulate hypothalamic-pituitary-adrenal activity and anxiety-related behavior regardless of prior stress experience.Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH.[(76) Br]BMK-152, a nonpeptide analogue, with high affinity and low nonspecific binding for the corticotropin-releasing factor type 1 receptor.Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking.Stress, alcohol and drug interaction: an update of human research.Restraint stress and ethanol consumption in two mouse strains.
P2860
Q24657105-63BF1DD7-EB88-4753-ABAC-81143A2EEB88Q26991739-F1874F74-7E06-4D86-89DD-4F7AA257A46EQ27016155-7678D8C8-BEFE-4AB2-BED5-CB63AC649613Q28480798-E26A930D-1566-4034-8927-64C051DD108AQ28484325-62EE0E57-A9CC-4F01-B67D-B1371EFE4CE1Q30404807-C0573859-ADC6-47EB-91F7-A6141CAF4EC1Q30455064-29A84B9D-40F2-4E17-AAD8-4928C9D56303Q30457677-C75ADFBF-1D0A-4D90-AF5A-199388553A07Q30463972-B46775E0-1F8F-48FF-ACE3-7499AFD3A65CQ30466695-CBA60564-8AA6-414B-B8EC-F80A5959AFB2Q30475129-B4EE0996-9C1D-41FF-84E9-A3F72C31E141Q30477934-9C60ABDF-87EC-4AC9-93FA-8DFFEEF03446Q30477987-3E2BD6E6-FFE6-420C-915E-A7C89656ED62Q30478689-59B3BA85-9F9F-4C71-B10B-42C73A129AE2Q30481020-01946113-32D3-45E0-A7D5-969570C4E11BQ30486793-2252D6EA-CA6B-4E3E-8CBC-E32A58B02D5BQ30488089-72A74E94-3E6E-475F-813D-24B0EDCB3BB0Q30499863-D250FB1C-9766-4AA4-A1F5-F673DDC1365AQ30502566-703CD4DB-2369-425D-A03E-2A510B55FD20Q30504140-209357C0-51B2-4776-8712-6FFB9D425F9AQ33153854-8E7F26B7-7AAE-436B-9AFF-9863D7004C91Q34002823-3BF3D7C1-E0B9-4916-A0ED-B8D2E110BE91Q34182992-A78B8112-1D1D-459E-BF48-1B448FFAA344Q34226624-15B2350A-2D54-414A-8D3C-C9EF20F6B3E4Q34228120-F1EB341E-6B7A-4A16-A4A7-0A19A943F568Q34330259-F791F1DA-9C2E-4815-8B05-A1D4D596CE5BQ34406540-F422E7B8-8807-44C4-A9DD-E6267053B260Q34421388-4343C1EF-0878-45C5-AFC7-B828BECA90C8Q34501795-C3FAB121-1D64-4580-88C8-B4D55F239F22Q34771642-D160689A-2884-4F13-912D-D7A6A958FDFCQ35142902-C575494A-4DDD-46E8-A4FB-F9AC4361AC8EQ35148867-954556AD-AD6E-4355-9427-CB26722D2184Q35812772-CD2227A1-BE7F-4C6A-A39B-B3426076D896Q36327724-4705A358-48B6-4EC4-91BC-49D09581F60CQ36328194-1C4F13C1-5795-436C-AFE5-ED4CF7DD1B41Q36419780-37F46D28-73F9-43CD-B77D-1CA1A42FFC86Q36764636-41919825-C171-4310-A706-4C3A3B00E1FBQ36900018-EE05CD03-F151-44B7-9586-386783ACA971Q37124698-48EC81D2-9AB3-4574-8A86-F1503F2A03A5Q37165684-D66601AE-1060-4CB1-B24D-4DF9BD1AE825
P2860
The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The impact of the nonpeptide c ...... endocrine responses to stress.
@ast
The impact of the nonpeptide c ...... endocrine responses to stress.
@en
The impact of the nonpeptide c ...... endocrine responses to stress.
@nl
type
label
The impact of the nonpeptide c ...... endocrine responses to stress.
@ast
The impact of the nonpeptide c ...... endocrine responses to stress.
@en
The impact of the nonpeptide c ...... endocrine responses to stress.
@nl
prefLabel
The impact of the nonpeptide c ...... endocrine responses to stress.
@ast
The impact of the nonpeptide c ...... endocrine responses to stress.
@en
The impact of the nonpeptide c ...... endocrine responses to stress.
@nl
P2093
P356
P1433
P1476
The impact of the nonpeptide c ...... endocrine responses to stress.
@en
P2093
Chrousos GP
Ehrlich AL
Spencer RL
Watkins LR
P356
10.1210/EN.140.1.79
P407
P577
1999-01-01T00:00:00Z